Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC
Clinical trial NCT07103447 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07103447
- Sponsor
- Shuangyue Liu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2027-12-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.